UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Conversion Rate towards a Syncytium-Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis

The Journal of infectious diseases, 1999-01, Vol.179 (1), p.254-258

1999

Volltextzugriff (PDF)

Longitudinal Analysis of CD4 T Cell Counts, T Cell Reactivity, and Human Immunodeficiency Virus Type 1 RNA Levels in Persons Remaining AIDS-Free despite CD4 Cell Counts <200 for >5 Years

The Journal of infectious diseases, 1997-09, Vol.176 (3), p.665-671

1997

Volltextzugriff (PDF)

Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study

Schizophrenia research, 2009-12, Vol.115 (2), p.104-114

2009

Volltextzugriff (PDF)

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

The Lancet (British edition), 2008-03, Vol.371 (9618), p.1085-1097

2008

Volltextzugriff (PDF)

In Vivo Delayed-Type Hypersensitivity Skin Test Anergy in Human Immunodeficiency Virus Type 1 Infection Is Associated with T Cell Nonresponsiveness In Vitro

The Journal of infectious diseases, 1998-10, Vol.178 (4), p.1024-1029

1998

Volltextzugriff (PDF)

Preventing chronicity in mental health: being present earlier within the network

Tijdschrift voor psychiatrie, 2021, Vol.63 (2), p.142-149

2021

Volltextzugriff (PDF)

Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial

European neuropsychopharmacology, 2013-03, Vol.23 (3), p.196-204

2013

Volltextzugriff (PDF)

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis

Psychological medicine, 2013-12, Vol.43 (12), p.2571-2582

2013

Volltextzugriff (PDF)

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men

The Journal of infectious diseases, 1994-06, Vol.169 (6), p.1244-1249

1994

Volltextzugriff (PDF)

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts

The Journal of infectious diseases, 1994-06, Vol.169 (6), p.1236-1243

1994

Volltextzugriff (PDF)

Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST)

The journal of clinical psychiatry, 2011-07, Vol.72 (7), p.955-961

2011

Volltextzugriff (PDF)

Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)

European neuropsychopharmacology, 2010-05, Vol.20 (5), p.310-316

2010

Volltextzugriff (PDF)

Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?

Journal of clinical psychopharmacology, 2010-04, Vol.30 (2), p.176-180

2010

Volltextzugriff (PDF)

Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective

Psychological medicine, 2012-07, Vol.42 (7), p.1461-1473

2012

Volltextzugriff (PDF)

Rapid Disease Progression in Human Immunodeficiency Virus Type 1—Infected Individuals with Adverse Reactions to Trimethoprim-Sulfamethoxazole Prophylaxis

Clinical infectious diseases, 1997-05, Vol.24 (5), p.936-941

1997

Volltextzugriff (PDF)

Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial

Journal of clinical psychopharmacology, 2013-04, Vol.33 (2), p.258-261

2013

Volltextzugriff (PDF)

Using resource groups in assertive community treatment; literature review and recommendation

Tijdschrift voor psychiatrie, 2017, Vol.59 (8), p.466-473

2017

Volltextzugriff (PDF)

Association between CCR5 genotype and the clinical course of HIV-1 infection

Annals of internal medicine, 1997-11, Vol.127 (10), p.882

1997

Volltextzugriff (PDF)

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS

Annals of internal medicine, 1993-05, Vol.118 (9), p.681

1993

Volltextzugriff (PDF)

Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST)

The journal of clinical psychiatry, 2010-01, Vol.71 (1), p.58-65

2010

Volltextzugriff (PDF)

Consistent Associations of HLA Class I and II and Transporter Gene Products with Progression of Human Immunodeficiency Virus Type 1 Infection in Homosexual Men

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.299-309

1999

Volltextzugriff (PDF)

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

The Lancet (British edition), 1998-05, Vol.351 (9115), p.1547-1551

1998

Volltextzugriff (PDF)

HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection

AIDS research and human retroviruses, 1999-03, Vol.15 (4), p.317-324

1999

Volltextzugriff (PDF)

Familial sinistrality and handedness in patients with first episode schizophrenia: The EUFEST study

Laterality (Hove), 2012-03, Vol.17 (2), p.217-224

2012

Volltextzugriff (PDF)

Programmed death of T cells in human immunodeficiency virus infection : no correlation with progression to disease

The Journal of clinical investigation, 1994-03, Vol.93 (3), p.982-988

1994

Volltextzugriff (PDF)

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Humans
(96)
Life Sciences & Biomedicine
(74)
Male
(58)
Biological And Medical Sciences
(48)
Computer Science
(48)
Computer Science, Theory & Methods
(48)
Technology
(48)
Computer Science, Information Systems
(47)
Computer Science, Artificial Intelligence
(45)
Medical Sciences
(44)
Adult
(37)
Female
(36)
Aids/hiv
(32)
Immunology
(29)
Infectious Diseases
(27)
Aids
(18)
Cohort Studies
(16)
Immunopathology
(16)
Microbiology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Conversion Rate towards a Syncytium-Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis

Longitudinal Analysis of CD4 T Cell Counts, T Cell Reactivity, and Human Immunodeficiency Virus Type 1 RNA Levels in Persons Remaining AIDS-Free despite CD4 Cell Counts <200 for >5 Years

Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

In Vivo Delayed-Type Hypersensitivity Skin Test Anergy in Human Immunodeficiency Virus Type 1 Infection Is Associated with T Cell Nonresponsiveness In Vitro

Preventing chronicity in mental health: being present earlier within the network

Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts

Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST)

Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)

Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?

Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective

Rapid Disease Progression in Human Immunodeficiency Virus Type 1—Infected Individuals with Adverse Reactions to Trimethoprim-Sulfamethoxazole Prophylaxis

Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial

Using resource groups in assertive community treatment; literature review and recommendation

Association between CCR5 genotype and the clinical course of HIV-1 infection

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS

Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST)

Consistent Associations of HLA Class I and II and Transporter Gene Products with Progression of Human Immunodeficiency Virus Type 1 Infection in Homosexual Men

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection

Familial sinistrality and handedness in patients with first episode schizophrenia: The EUFEST study

Programmed death of T cells in human immunodeficiency virus infection : no correlation with progression to disease

Suchergebnisse filtern